UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 252

Sortiert nach

Gynecologic health and disease in relation to the microbiome of the female reproductive tract

Fertility and sterility, 2015-12, Vol.104 (6), p.1351-1357

2015

Volltextzugriff (PDF)

Pathogenesis of uterine fibroids: current understanding and future directions

Fertility and sterility, 2024-07, Vol.122 (1), p.6-11

2024

Volltextzugriff (PDF)

Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma

Seminars in reproductive medicine, 2013-09, Vol.31 (5), p.370

2013

Volltextzugriff (PDF)

Prevalence, morbidity, and current medical management of uterine leiomyomas

International journal of gynecology and obstetrics, 2015-11, Vol.131 (2), p.117-122

2015

Volltextzugriff (PDF)

Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production

Fertility and sterility, 2018-12, Vol.110 (7), p.1398-1407.e1

2018

Volltextzugriff (PDF)

Simvastatin ameliorates altered mechanotransduction in uterine leiomyoma cells

American journal of obstetrics and gynecology, 2020-11, Vol.223 (5), p.733.e1-733.e14

2020

Volltextzugriff (PDF)

The Investigation and Management of Adenomyosis in Women Who Wish to Improve or Preserve Fertility

BioMed research international, 2018-01, Vol.2018, p.6832685-12

2018

Volltextzugriff (PDF)

Development and Validation of Hormonal Impact of a Mouse Xenograft Model for Human Uterine Leiomyoma

Reproductive sciences (Thousand Oaks, Calif.), 2020-06, Vol.27 (6), p.1304-1317

2020

Volltextzugriff (PDF)

Ulipristal acetate decreases active TGF-β3 and its canonical signaling in uterine leiomyoma via two novel mechanisms

Fertility and sterility, 2019-04, Vol.111 (4), p.806-815.e1

2019

Volltextzugriff (PDF)

Possible involvement of inflammatory/reparative processes in the development of uterine fibroids

Cell and tissue research, 2016-05, Vol.364 (2), p.415-427

2016

Volltextzugriff (PDF)

Vitamin D: Mechanism of Action and Biological Effects in Uterine Fibroids

Nutrients, 2021-02, Vol.13 (2), p.597

2021

Volltextzugriff (PDF)

Uterine fibroids

Nature reviews. Disease primers, 2016-06, Vol.2 (1), p.16043-16043, Article 16043

2016

Volltextzugriff (PDF)

A Review of GnRH Antagonists as Treatment for Abnormal Uterine Bleeding-Leiomyoma (AUB-L) and Their Influence on the Readiness of Service Members

Military medicine, 2023-07, Vol.188 (7-8), p.e1620-e1624

2023

Volltextzugriff (PDF)

Proceedings from the National Institute of Child Health and Human Development Conference on the Uterine Fibroid Research Update Workshop

Fertility and sterility, 2011, Vol.95 (1), p.9-12

2011

Volltextzugriff (PDF)

Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women

Seminars in reproductive medicine, 2010-05, Vol.28 (3), p.169

2010

Volltextzugriff (PDF)

Development and validation of a three-dimensional in vitro model for uterine leiomyoma and patient-matched myometrium

Fertility and sterility, 2012-06, Vol.97 (6), p.1287-1293

2012

Volltextzugriff (PDF)

Evaluation of an embryology and genetic testing patient counseling education intervention for reproductive endocrinology nurses

Fertility and sterility, 2019-08, Vol.112 (2), p.275-282.e1

2019

Volltextzugriff (PDF)

Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial

Reproductive sciences (Thousand Oaks, Calif.), 2018-02, Vol.25 (2), p.198-206

2018

Volltextzugriff (PDF)

Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones

Fertility and sterility, 2016, Vol.105 (1), p.214-224

2016

Volltextzugriff (PDF)

Race matters: a systematic review of racial/ethnic disparity in Society for Assisted Reproductive Technology reported outcomes

Fertility and sterility, 2012-08, Vol.98 (2), p.406-409

2012

Volltextzugriff (PDF)

A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma

BioMed research international, 2018-01, Vol.2018, p.2414609-11

2018

Volltextzugriff (PDF)

Mifepristone inhibits extracellular matrix formation in uterine leiomyoma

Fertility and sterility, 2016-04, Vol.105 (4), p.1102-1110

2016

Volltextzugriff (PDF)

The efficacy of medical management of leiomyoma-associated heavy menstrual bleeding: a mini review

F&S Reports (Online), 2024-03, Vol.5 (1), p.4-8

2024

Volltextzugriff (PDF)

Coenzyme Q-10 reduced the aberrant production of extracellular matrix proteins in uterine leiomyomas through transforming growth factor beta 3

F&S Science (Online), 2024-07

2024

Volltextzugriff (PDF)

Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation

Pharmacological research, 2021-10, Vol.172, p.105856-105856, Article 105856

2021

Volltextzugriff (PDF)

1 – 25 von 252

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(242)
Mit Volltextzugriff
(244)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Gynecologic health and disease in relation to the microbiome of the female reproductive tract

Pathogenesis of uterine fibroids: current understanding and future directions

Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma

Prevalence, morbidity, and current medical management of uterine leiomyomas

Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production

Simvastatin ameliorates altered mechanotransduction in uterine leiomyoma cells

The Investigation and Management of Adenomyosis in Women Who Wish to Improve or Preserve Fertility

Development and Validation of Hormonal Impact of a Mouse Xenograft Model for Human Uterine Leiomyoma

Ulipristal acetate decreases active TGF-β3 and its canonical signaling in uterine leiomyoma via two novel mechanisms

Possible involvement of inflammatory/reparative processes in the development of uterine fibroids

Vitamin D: Mechanism of Action and Biological Effects in Uterine Fibroids

Uterine fibroids

A Review of GnRH Antagonists as Treatment for Abnormal Uterine Bleeding-Leiomyoma (AUB-L) and Their Influence on the Readiness of Service Members

Proceedings from the National Institute of Child Health and Human Development Conference on the Uterine Fibroid Research Update Workshop

Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women

Development and validation of a three-dimensional in vitro model for uterine leiomyoma and patient-matched myometrium

Evaluation of an embryology and genetic testing patient counseling education intervention for reproductive endocrinology nurses

Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial

Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones

Race matters: a systematic review of racial/ethnic disparity in Society for Assisted Reproductive Technology reported outcomes

A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma

Mifepristone inhibits extracellular matrix formation in uterine leiomyoma

The efficacy of medical management of leiomyoma-associated heavy menstrual bleeding: a mini review

Coenzyme Q-10 reduced the aberrant production of extracellular matrix proteins in uterine leiomyomas through transforming growth factor beta 3

Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation

Suchergebnisse filtern